John C. Burnett Jr., M.D.![]() John C. Burnett Jr., M.D.
Location:
Minnesota
SummaryJohn C. Burnett Jr., M.D., studies the endocrine role of the heart in cardiorenal homeostasis with a focus on the natriuretic peptides in heart failure, hypertension and myocardial infarction. The long-term goal is the engineering and clinical development of novel designer natriuretic peptides for the treatment of human cardiorenal disease, including the development of innovative natriuretic peptide-based diagnostics. With continuous funding from the National Institutes of Health, Dr. Burnett and his team have developed three novel designer peptides currently in clinical trials targeting heart failure and resistant hypertension. From this work, seven patents have been awarded and three new biotechnology companies founded. Focus areas
Significance to patient careDr. Burnett's research is of high clinical impact. Specifically, his research addresses the huge unmet need for new drugs and biomarkers for cardiorenal disease. Progress in these areas may truly lead to reducing the burden of human disease. Professional highlights
Recent publicationsEducation
Fellowship
–
Clinical Cardiology
Research Fellowship
–
NIH Research Fellow, Nephrology Research Laboratory
Residency
–
Internal Medicine
Internship
–
Internal Medicine
M.D.
–
Research Fellowship
–
B.S.
–
Physiology
Other
–
|
LEGAL RESTRICTIONS AND TERMS OF USE APPLICABLE TO THIS SITE
Use of this site signifies your agreement to the terms of use.
© 2013 Mayo Foundation for Medical Education and Research. All rights reserved.